These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Marampon F, Bossi G, Ciccarelli C, Di Rocco A, Sacchi A, Pestell RG, Zani BM. Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428 [Abstract] [Full Text] [Related]
4. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population. Ciccarelli C, Vulcano F, Milazzo L, Gravina GL, Marampon F, Macioce G, Giampaolo A, Tombolini V, Di Paolo V, Hassan HJ, Zani BM. Mol Cancer; 2016 Feb 20; 15():16. PubMed ID: 26897742 [Abstract] [Full Text] [Related]
5. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Kouraklis G, Triche TJ, Wesley R, Tsokos M. Pediatr Res; 1999 Apr 20; 45(4 Pt 1):552-8. PubMed ID: 10203148 [Abstract] [Full Text] [Related]
10. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo. Ciccarelli C, Di Rocco A, Gravina GL, Mauro A, Festuccia C, Del Fattore A, Berardinelli P, De Felice F, Musio D, Bouché M, Tombolini V, Zani BM, Marampon F. J Cancer Res Clin Oncol; 2018 Sep 06; 144(9):1685-1699. PubMed ID: 29959569 [Abstract] [Full Text] [Related]
12. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A. Int J Oncol; 2005 Sep 06; 27(3):791-8. PubMed ID: 16077930 [Abstract] [Full Text] [Related]
13. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C. J Natl Cancer Inst; 2011 Apr 20; 103(8):645-61. PubMed ID: 21464397 [Abstract] [Full Text] [Related]
14. MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, Fardella C, Polidoro L, Ciccarelli C, Festuccia C, Popov VM, Pestell RG, Tombolini V, Zani BM. Mol Cancer Ther; 2011 Jan 20; 10(1):159-68. PubMed ID: 21220498 [Abstract] [Full Text] [Related]
16. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay. Marampon F, Gravina GL, Zani BM, Popov VM, Fratticci A, Cerasani M, Di Genova D, Mancini M, Ciccarelli C, Ficorella C, Di Cesare E, Festuccia C. Int J Oncol; 2014 Jun 20; 44(6):2121-31. PubMed ID: 24676782 [Abstract] [Full Text] [Related]
17. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation. Liu Y, Zhang L, Liu Y, Sun C, Zhang H, Miao G, Di CX, Zhou X, Zhou R, Wang Z. J Cell Physiol; 2015 May 20; 230(5):1094-103. PubMed ID: 25294801 [Abstract] [Full Text] [Related]